Effect of anti-CD134L mAb and CTLA4Ig on ConA-induced proliferation, Th cytokine secretion, and anti-dsDNA antibody production in spleen cells from lupus-prone BXSB mice

References

• Liang B, Kashgarian MJ, Sharpe AH, Mamula MJ. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus. J Immunol 2000; 165: 3436–3443
   PubMed Web of Science ®Google Scholar
• Yuan X, Salama AD, Dong V, Schmitt I, Najafian N, Chandraker A, Akiba H, Yagita H, Sayegh MH. The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo. J Immunol 2003; 170: 2949–2955
   PubMed Web of Science ®Google Scholar
• Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 1813–1821
   PubMed Web of Science ®Google Scholar
• Walunas TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 2541–2550
   PubMed Web of Science ®Google Scholar
• Linsley PS, Wallace PM, Johnson J, Gibson MG, Greene JL, Ledbetter JA, Singh C, Tepper MA. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992; 257: 792–795
   PubMed Web of Science ®Google Scholar
• Mihara M, Tan I, Chuzhin Y, Reddy B, Budhai L, Holzer A, Gu Y, Davidson A. CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus. J Clin Invest 2000; 106: 91–101
   PubMed Web of Science ®Google Scholar
• Yamada A, Salama AD, Sayegh MH. The role of novel T cell costimulatory pathways in autoimmunity and transplantation. J Am Soc Nephrol 2002; 13: 559–575
   PubMed Web of Science ®Google Scholar
• Takeda I, Ine S, Killeen N, Ndhlovu LC, Murata K, Satomi S, Sugamura K, Ishii N. Distinct roles for the OX40–OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol 2004; 172: 3580–3589
   PubMed Web of Science ®Google Scholar
• Chitnis T, Najafian N, Abdallah KA, Dong V, Yagita H, Sayegh MH, Khoury SJ. CD28-independent induction of experimental autoimmune encephalomyelitis. J Clin Invest 2001; 107: 575–583
   PubMed Web of Science ®Google Scholar
• Gramaglia I, Weinberg AD, Lemon M, Croft M. Ox-40 ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol 1998; 161: 6510–6517
   PubMed Web of Science ®Google Scholar
• Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T cell development and function. Annu Rev Immunol 2000; 18: 309–345
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Kristofic C. Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO− and CD45RO+ subsets. J Immunol 1995; 155: 3322–3328
   PubMed Web of Science ®Google Scholar
• Eisenberg RA, Izui S, McConahey PJ, Hang L, Peters CJ, Theofilopoulos AN, Dixon FJ. Male determined accelerated autoimmune disease in BXSB mice: Transfer by bone marrow and spleen cells. J Immunol 1980; 125: 1032–1036
   PubMed Web of Science ®Google Scholar
• Izui S, Iwamoto M, Fossati L, Merino R, Takahashi S, Ibnou-Zekri N. The Yaa gene model of systemic lupus erythematosus. Immunol Rev 1995; 144: 137–156
   PubMed Web of Science ®Google Scholar
• Zhou DH, Shen YS, Zhao MR. MTT colorimetry: A new approach to measurement of lymphocyte transformation and mice lL-2 activity. J Chin Immunol 1986; 2: 39–44
   Google Scholar
• Richaud-Patin Y, Alcocer-Varela J, Llorente L. High levels of Th2 cytokine gene expression in systemic lupus erythematosus. Rev Invest Clin 1995; 47: 267–272
   PubMedGoogle Scholar
• Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot MC, Durand-Gasselin I, Fourrier BM, Galanaud P, Emilie D. Spontaneous production of IL-10 by B lymphocytes and monocytes in SLE. Eur Cytokine Netw 1993; 4: 421–427
   PubMed Web of Science ®Google Scholar
• Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol 2001; 54: 211–219
   PubMed Web of Science ®Google Scholar
• Buttgereit F, Wehling M, Burmester GR. A new hypothesis of modular glucocorticoid actions: Steroid treatment of rheumatic disease revisited. Arthritis Rheum 1998; 41: 761–767
   PubMed Web of Science ®Google Scholar
• Moser M, De Smedt T, Sornasse T, Tielemans F, Chentoufi AA, Muraille E, Van Mechelen M, Urbain J, Leo O. Glucocorticoids down-regulate dendritic cells function in vitro and in vivo. Eur J Immunol 1995; 25: 2818–2824
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin Sci (London) 1998; 94: 557–572
   PubMed Web of Science ®Google Scholar
• Vandenborre K, Van Gool SW, Kasran A, Ceuppens JL, Boogaerts MA, Vandenberghe P. Interaction of CTLA4 (CD152) with CD80 or CD86 inhibits human T-cell activation. Immunology 1999; 98: 413–421
   PubMed Web of Science ®Google Scholar
• Davidson A, Diamond B, Wofsy D, Daikh D. Block and tackle: CTLA4Ig takes on lupus. Lupus 2005; 14: 197–203
   PubMed Web of Science ®Google Scholar
• Schiffer L, Sinha J, Wang X, Huang W, von Gersdorff G, Schiffer M, Madaio MP, Davidson A. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol 2003; 171: 489–497
   PubMed Web of Science ®Google Scholar
• Akkerman A, Huang W, Wang X, Ramanujam M, Schiffer L, Madaio M, Factor SM, Davidson A. CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice. Autoimmunity 2004; 37: 445–451
   PubMed Web of Science ®Google Scholar
• Daikh DI, Finck BK, Linsley PS, Hollenbaugh D, Wofsy D. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol 1997; 159: 3104–3108
   PubMed Web of Science ®Google Scholar
• Blaha P, Bigenzahn S, Koporc Z, Schmid M, Langer F, Selzer E, Bergmeister H, Wrba F, Kurtz J, Kiss C, Roth E, Muehlbacher F, Sykes M, Wekerle T. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 2003; 101: 2886–2893
   PubMed Web of Science ®Google Scholar
• Kita Y, Li XK, Funeshima N, Enosawa S, Tamura A, Hayashi S, Suzuki K, Kazui T, Amemiya H, Suzuki S. Prolonged graft survival induced by CTLA4IG-gene transfection combined with FTY720 administration in rat heart grafting. Transplant Proc 1999; 31: 2787–2788
   PubMed Web of Science ®Google Scholar
• Ramanujam M, Wang X, Huang W, Schiffer L, Grimaldi C, Akkerman A, Diamond B, Madaio MP, Davidson A. Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus. J Immunol 2004; 173: 3524–3534
   PubMed Web of Science ®Google Scholar
• Flynn S, Toellner KM, Raykundalia C, Goodall M, Lane P. CD4 T cell cytokine differentiation: The B cell activation molecule. OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of chemokine receptor, Blr-1. J Exp Med 1998; 188: 297–304
   PubMed Web of Science ®Google Scholar
• Akiba H, Miyahira Y, Atsuta M, Takeda K, Nohara C, Futagawa T, Matsuda H, Aoki T, Yagita H, Okumura K. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J Exp Med 2000; 191: 375–380
   PubMed Web of Science ®Google Scholar
• Ndhlovu LC, Ishii N, Murata K, Sato T, Sugamura K. Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis. J Immunol 2001; 167: 2991–2999
   PubMed Web of Science ®Google Scholar
• Murata K, Ishii N, Takano H, Miura S, Ndhlovu LC, Nose M, Noda T, Sugamura K. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J Exp Med 2000; 191: 365–374
   PubMed Web of Science ®Google Scholar
• Arestides RS, He H, Westlake RM, Chen AI, Sharpe AH, Perkins DL, Finn PW. Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol 2002; 32: 2874–2880
   PubMed Web of Science ®Google Scholar
• Patschan S, Dolff S, Kribben A, Dürig J, Patschan D, Wilde B, Specker C, Philipp T, Witzke O. CD134 expression on CD4+T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus. Clin Exp Immunol 2006; 145: 235–242
   PubMed Web of Science ®Google Scholar
• Kaleeba JA, Offner H, Vandenbark AA, Lublinski A, Weinberg AD. The OX40 receptor provides a potent costimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+T cells. Int Immunol 1998; 10: 453–461
   PubMed Web of Science ®Google Scholar
• Walker LS, Gulbranson-Judge A, Flynn S, Brocker T, Lane PJ. Co-stimulation and selection for T-cell help for germinal centers: The role of CD28 and OX40. Immunol Today 2000; 21: 333–337
   PubMedGoogle Scholar